RFG
HRMY icon

RFP Financial Group’s Harmony Biosciences HRMY Stock Holding History

RFP Financial Group’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-18
Closed -$581 – 896
2023
Q4 		$581 Hold
18
– – ﹤0.01% 827
2023
Q3 		$590 Hold
18
– – ﹤0.01% 842
2023
Q2 		$633 Hold
18
– – ﹤0.01% 875
2023
Q1 		$588 Hold
18
– – ﹤0.01% 695
2022
Q4 		$992 Buy
+18
New +$990 ﹤0.01% 774

Other funds holding HRMY

VM
Valor Management Chicago, Illinois $181M AUM 6.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

RFP Financial Group's HRMY Position: Q1 2024 in Review

RFP Financial Group sold out of Harmony Biosciences (HRMY) in Q1 2024, closing a stake of 18 shares — an estimated $581 sold.

RFP Financial Group first reported a position in HRMY in Q4 2022 and held it in 5 quarters. The position peaked at $992 in Q4 2022. 208 funds tracked by Wall St. Rank hold HRMY as of Q1 2024.

  • RFP Financial Group reported no remaining Harmony Biosciences position as of Q1 2024 after selling out during the quarter.
  • RFP Financial Group sold 18 Harmony Biosciences shares in Q1 2024, an estimated $581.
  • RFP Financial Group first reported a position in Harmony Biosciences in Q4 2022 and held it in 5 quarters.
  • RFP Financial Group's Harmony Biosciences position peaked at $992 in Q4 2022.
  • 208 funds tracked by Wall St. Rank held Harmony Biosciences as of Q1 2024.

Based on RFP Financial Group's 13F filing for Q1 2024, filed 9 May 2024.